COMPUTE BEYOND NATURE
08/30/2022 Fierce Biotech: Arch builds bridge to new class of medicines, leading $50M investment in the AI-enabled Vilya
08/29/2022 Vilya launches to design a new transformational class of medicines that precisely target disease biology
08/29/2022 UW Institute for Protein Design: Design of membrane-traversing peptides leads to new spinout
08/29/2022 Timmerman Report: Arch bets $50M on Vilya, Baker Lab Spinout to Make Targeted, Oral Peptide Drugs
© 2023 Vilya, Inc. All Rights Reserved.